Okusaka T - Search Results

1

Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients.

Ueno H, Kaniwa N, Okusaka T, Ikeda M, Morizane C, Kondo S, Sugiyama E, Kim SR, Hasegawa R, Saito Y, Yoshida T, Saijo N, Sawada J. Ueno H, et al. Among authors: okusaka t. Br J Cancer. 2009 Mar 24;100(6):870-3. doi: 10.1038/sj.bjc.6604971. Br J Cancer. 2009. PMID: 19293806 Free PMC article.

2

Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.

Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H. Ishii H, et al. Among authors: okusaka t. Cancer. 1997 Apr 15;79(8):1516-20. Cancer. 1997. PMID: 9118032 Clinical Trial.

3

Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma.

Nagahama H, Okada S, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Yoshimori M. Nagahama H, et al. Among authors: okusaka t. Jpn J Clin Oncol. 1997 Oct;27(5):321-4. doi: 10.1093/jjco/27.5.321. Jpn J Clin Oncol. 1997. PMID: 9390209

4

Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.

Okusaka T, Okada S, Ishii H, Ikeda M, Nakasuka H, Nagahama H, Iwata R, Furukawa H, Takayasu K, Nakanishi Y, Sakamoto M, Hirohashi S, Yoshimori M. Okusaka T, et al. Oncology. 1998 Jul-Aug;55(4):276-83. doi: 10.1159/000011863. Oncology. 1998. PMID: 9663415 Clinical Trial.

5

Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.

Okada S, Sato T, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Kosakamoto H, Yoshimori M, Wakabayashi K. Okada S, et al. Among authors: okusaka t. Br J Cancer. 1998 Jun;77(11):2028-31. doi: 10.1038/bjc.1998.337. Br J Cancer. 1998. PMID: 9667687 Free PMC article.

6

Undifferentiated carcinoma of the liver with neuroendocrine features: a case report.

Nakasuka H, Okada S, Okusaka T, Ishii H, Ikeda M, Ito R, Kosakamoto H, Yoshimori M, Nakanishi Y, Sakamoto M. Nakasuka H, et al. Among authors: okusaka t. Jpn J Clin Oncol. 1998 Jun;28(6):401-4. doi: 10.1093/jjco/28.6.401. Jpn J Clin Oncol. 1998. PMID: 9730157

7

Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.

Okusaka T, Eguchi K, Kasai T, Kurata T, Yamamoto N, Ohe Y, Tamura T, Shinkai T, Saijo N. Okusaka T, et al. Clin Cancer Res. 1997 Jan;3(1):123-7. Clin Cancer Res. 1997. PMID: 9815547

8

Prognosis of advanced pancreatic cancer patients with reference to calorie intake.

Okusaka T, Okada S, Ishii H, Ikeda M, Kosakamoto H, Yoshimori M. Okusaka T, et al. Nutr Cancer. 1998;32(1):55-8. doi: 10.1080/01635589809514717. Nutr Cancer. 1998. PMID: 9824858

9

A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.

Kosakamoto H, Okada S, Ueno H, Okusaka T, Ikeda M, Tanaka N, Yoshimori M, Matsuno Y. Kosakamoto H, et al. Among authors: okusaka t. Hepatogastroenterology. 1999 Jul-Aug;46(28):2621-4. Hepatogastroenterology. 1999. PMID: 10522052

10

Clinicopathological features in misdiagnosed pancreatic carcinoma.

Nagahama H, Okada S, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Yoshimori M. Nagahama H, et al. Among authors: okusaka t. Hepatogastroenterology. 1999 Sep-Oct;46(29):2983-5. Hepatogastroenterology. 1999. PMID: 10576387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters